TSC1 activates TGF-β-Smad2/3 signaling in growth arrest and epithelial-to-mesenchymal transition

Developmental Cell
Antje ThienKathrin Thedieck

Abstract

The tuberous sclerosis proteins TSC1 and TSC2 are key integrators of growth factor signaling. They suppress cell growth and proliferation by acting in a heteromeric complex to inhibit the mammalian target of rapamycin complex 1 (mTORC1). In this study, we identify TSC1 as a component of the transforming growth factor β (TGF-β)-Smad2/3 pathway. Here, TSC1 functions independently of TSC2. TSC1 interacts with the TGF-β receptor complex and Smad2/3 and is required for their association with one another. TSC1 regulates TGF-β-induced Smad2/3 phosphorylation and target gene expression and controls TGF-β-induced growth arrest and epithelial-to-mesenchymal transition (EMT). Hyperactive Akt specifically activates TSC1-dependent cytostatic Smad signaling to induce growth arrest. Thus, TSC1 couples Akt activity to TGF-β-Smad2/3 signaling. This has implications for cancer treatments targeting phosphoinositide 3-kinases and Akt because they may impair tumor-suppressive cytostatic TGF-β signaling by inhibiting Akt- and TSC1-dependent Smad activation.

References

Aug 8, 1997·Science·M van SlegtenhorstD J Kwiatkowski
Mar 21, 1998·Science·Z G WangP P Pandolfi
Aug 5, 1998·Proceedings of the National Academy of Sciences of the United States of America·M WeinsteinC X Deng
Mar 3, 1999·Proceedings of the National Academy of Sciences of the United States of America·S RamaswamyW R Sellers
Jun 3, 1999·Oncogene·N HornigoldM A Knowles
Oct 27, 1999·Proceedings of the National Academy of Sciences of the United States of America·J HeyerR Kucherlapati
Nov 30, 2000·Molecular and Cellular Biology·S MiuraK Sugamura
Jul 5, 2001·Proceedings of the National Academy of Sciences of the United States of America·T KobayashiO Hino
Aug 13, 2002·Nature Cell Biology·Ken InokiKun-Liang Guan
Aug 13, 2002·Nature Cell Biology·Christopher J PotterTian Xu
Sep 25, 2002·Proceedings of the National Academy of Sciences of the United States of America·Andrew R TeeJohn Blenis
Jan 9, 2003·The Journal of Biological Chemistry·David R Plas, Craig B Thompson
Apr 30, 2003·Nature Cell Biology·Gianni M Di GuglielmoJeffrey L Wrana
Mar 9, 2004·Cell Cycle·Tohru MinaminoIssei Komuro
Mar 30, 2004·Nature Cell Biology·Ingrid RemyStephen W Michnick
Apr 7, 2004·The Journal of Biological Chemistry·Maria C Birchenall-RobertsFrancis W Ruscetti
Sep 10, 2004·Nature·Hui-Kuan LinPier Paolo Pandolfi
Oct 8, 2005·International Journal of Oncology·Margit RosnerMarkus Hengstschläger
Dec 21, 2005·The Journal of Cell Biology·Hanna Y IrieJoan S Brugge
Mar 16, 2006·Proceedings of the National Academy of Sciences of the United States of America·Hong LiuMina J Bissell
Apr 26, 2006·The Journal of Cell Biology·Sheng-Li CaiCheryl Lyn Walker
Oct 3, 2006·The Journal of Biological Chemistry·Guo-Lei ZhouJeffrey Field
Feb 3, 2007·The Journal of Biological Chemistry·Ye-Guang ChenZhongxian Lu
Apr 27, 2007·Proceedings of the National Academy of Sciences of the United States of America·Xiaoming JuRichard G Pestell
Apr 10, 2008·Human Molecular Genetics·Louis S PymarMargaret A Knowles
Jul 16, 2008·Methods : a Companion to Methods in Enzymology·Ola SöderbergUlf Landegren
Feb 25, 2009·Current Opinion in Cell Biology·Carl-Henrik HeldinAristidis Moustakas
Mar 20, 2009·Human Molecular Genetics·Ken Inoki, Kun-Liang Guan
Mar 26, 2009·BioEssays : News and Reviews in Molecular, Cellular and Developmental Biology·Marek LosKlaus Schulze-Osthoff
Oct 15, 2009·Science Signaling·Dimitrios IliopoulosPhilip N Tsichlis
Feb 12, 2010·Annals of the New York Academy of Sciences·Ksenia A Orlova, Peter B Crino
Jun 16, 2010·Biochimica Et Biophysica Acta·Marianne Hoogeveen-WesterveldMark Nellist

❮ Previous
Next ❯

Citations

Jun 6, 2015·Cellular Oncology (Dordrecht)·Damián E BerardiLaura B Todaro
Jul 2, 2016·Journal of Clinical Medicine·Aristidis Moustakas, Carl-Henrik Heldin
Feb 6, 2018·Cellular and Molecular Life Sciences : CMLS·Thomas RosengrenLisbeth Birk Møller
Oct 4, 2018·Oncotarget·Yujuan ZhouDeliang Cao
Feb 16, 2017·Nature Immunology·Antonio J Pagán, Lalita Ramakrishnan
Oct 27, 2017·Science China. Life Sciences·Qiaoni Shi, Ye-Guang Chen
May 23, 2018·Proceedings of the National Academy of Sciences of the United States of America·Oded VolovelskyRaphael Kopan
Jan 6, 2019·International Journal of Molecular Sciences·Martyna PakułaKrzysztof Książek
Jul 8, 2020·International Journal of Molecular Sciences·Boris Y ShorningHelen B Pearson
Mar 30, 2019·Life Science Alliance·Alexander Martin HeberleKathrin Thedieck
Feb 11, 2020·The Journal of Clinical Investigation·Guangxin LiGeorge Tellides
Oct 30, 2020·Cancers·Vivian Weiwen XuePatrick Ming-Kuen Tang
Jan 27, 2021·Cell·Mirja Tamara PrentzellKathrin Thedieck
Feb 13, 2021·Molecular and Cellular Biochemistry·Karthik Mallela, Arun Kumar
Apr 10, 2021·Scientific Reports·Karthik MallelaArun Kumar
Sep 10, 2021·Scientific Reports·Yuta TakanezawaRieko Muramatsu

❮ Previous
Next ❯

Related Concepts

Related Feeds

AKT Pathway

This feed focuses on the AKT serine/threonine kinase, which is an important signaling pathway involved in processes such as glucose metabolism and cell survival.

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis

Apoptosis in Cancer

Apoptosis is an important mechanism in cancer. By evading apoptosis, tumors can continue to grow without regulation and metastasize systemically. Many therapies are evaluating the use of pro-apoptotic activation to eliminate cancer growth. Here is the latest research on apoptosis in cancer.